Dr. Eisfeld is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-7526
Education & Training
- Ohio State University HospitalResidency, Internal Medicine, 2016 - 2019
- University of Leipzig Faculty of MedicineClass of 2007
Certifications & Licensure
- OH State Medical License 2018 - 2027
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies.Nadeen Anabtawi, Deedra Nicolet, Najla Alotaibi, Daelynn R Buelow, Shelley Orwick
Leukemia. 2025-03-01 - 2 citationsLong-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy.Federico Mosna, Erika Borlenghi, Mark Litzow, John C Byrd, Cristina Papayannidis
Haematologica. 2025-03-01 - 1 citationsSingle-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype.Aino-Maija Leppä, Karen Grimes, Hyobin Jeong, Frank Y Huang, Alvaro Andrades
Nature Genetics. 2024-12-01
Abstracts/Posters
- DNA Methylation-Based Classification Highlights the Role of the JAK-STAT Pathway in Acute Myeloid LeukemiaAnn-Kathrin Eisfeld, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Distinct Gene Expression Profiles and Mutations Associate with Outcome in Younger Adults with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (Alliance)Ann-Kathrin Eisfeld, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A 14q32.31 Genomic-Imprinted DLK1-DIO3 microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer ImmunityAnn-Kathrin Eisfeld, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- The 2017 European Leukemianet Genetic Risk Classification Performs Poorly in Older Patients with Acute Myeloid Leukemia (AML) and Should be Refined to Identify Patient...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Mutations in Genes Associated with Familial Predisposition to Myeloid Neoplasms: Their Frequency and Associations with Pretreatment Characteristics in Adult Patients (...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Clinical and Molecular Characteristics of Acute Myeloid Leukemia (AML) Patients with TP53 Mutations and TP73 Mutations2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Study Identifies Genetic Factors Crucial in Acute Myeloid Leukemia Survival for Black PatientsOctober 11th, 2024
- The Long Non-Coding RNA HOXB-AS3 Regulates Ribosomal RNA Transcription in NPM1-Mutated Acute Myeloid LeukemiaNovember 25th, 2019
- AML Study Correlates Gene Mutations with 34 Disease SubgroupsMarch 21st, 2017
Grant Support
- Towards an inclusive genomic risk classification for acute myeloid leukemia (AML)OHIO STATE UNIVERSITY2023–2028
- The role of inflammation in the regulation of immune response in acute myeloid leukemiaNEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2028
- Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AMLOHIO STATE UNIVERSITY2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: